Katherine "Katie" Rubino, a partner at Wiggin and Dana LLP, advises clients in the life sciences industry on transactions involving intellectual property rights, research collaborations, licensing, financings, mergers and acquisitions, and public offerings. Rubino primarily acts for life sciences companies developing pharmaceuticals, vaccines, medical devices, antibody products, and digital health.
Legal 500 Editorial commentary
Accolades
Boston Elite
Key clients
- Cila Therapeutics
Work highlights
Assisted Cila Therapeutics with global patent filings and strategy that secured a grant from the National Institutes of Health to advance its CIL-Key platform, a novel technology that improves RNA delivery to lung epithelial cells.